期刊文献+

组合人工肾、血液透析滤过、血液透析对尿毒症脑病患者β2-微球蛋白的研究 被引量:9

Combination of artificial kidney dialysis, blood filtration hemodialysis patients with uremia encephalopathy β2-microglobulin removal research
下载PDF
导出
摘要 目的探讨组合人工肾、血液透析滤过、血液透析对尿毒症脑病(UE)患者β2-微球蛋白(β2-MG)的清除效果。方法选择180例UE患者,随机分为3组,普通血液透析(HD)组、血液滤过(HDF)组和组合人工肾组(HD+HP),每组60例。普通透析组行3次/w的血液透析治疗,血滤组在3次/w透析的中间一次用HDF模式,组合人工肾组在3次/w透析的中间一次用HD+HP模式,总疗程为6w。结果治疗6w后,3组患者的血肌酐、尿素氮、白蛋白、血红蛋白等治疗前后比较,差异无统计学意义(均P>0.05)。HD组透析前血β2-MG与治疗前比较,差异无统计学意义(P>0.05);HDF组血β2-MG从(34.05±4.08)mg·L^(-1)降至(22.49±3.51)mg·L^(-1),与治疗前相比,差异有统计学意义(P<0.05);HD+HP组β2-MG从(34.43±4.21)mg·L^(-1)降至(16.36±3.12)mg·L^(-1),与治疗前相比,差异有统计学意义(P<0.05)。3组对比HD+HP组血β2-MG下降水平明显低于HDF组和HD组(P<0.05)。结论组合人工肾可以更有效地清除UE患者血中的β2-MG。 Objective To investigate the effect of combined artificial kidney, hemodia filtration and hemodialysis on the removal of β2-microglobulin (β2-MG) in uremic encephalopathy ( UE ) . Method A retrospective randomized controlled study was used. Select 180 patients with UE.Randomly divided into three groups: hemodialysis ( HD ) group, hemodialysis filtration ( HDF ) group and the combination of artificial kidney ( HD+HP ) group, 60 cases/groups, hemodialysis group is 3/w blood dialysis. Hemodialysis filtration group is in the middle of 3/ w dialysis in a HDF mode. The combined artificial kidney group is used in the middle of 3/w dialysis in a HD+HP mode. The total course of treatment is 6w. Results 6 weeks after treatment.Three group of patients with serum creatinine, blood urea nitrogen, albumin, hemoglobin before and after treatment and compared differences had no statistical significance ( P〉0.05 ) . HD group : blood dialysis before, β 2-MG there was no statistically significant difference compared with before treatment ( P〉0.05 ) ; HDF group: blood β2-MG from ( 34.05±4.08 )mg·L^-1, fell to ( 22.49±3.51 )mg·L^-1.The difference was statistically significant compared with before treatment ( P〈0.05 ) ; HD+HPgroup: β2-MG from(34.43±4.21) mg·L^-1 fell to (16.36±3.12) mg·L^-1. The difference was statistically significant compared with before treatment ( P〈0.05 ) . 3 contrast HD+HP group blood β2-MG falling levels significantly lower than the HDF and HD group ( P〈0.05 ) . Conclusion Combination of artificial kidney can effectively remove UE patients blood β2-MG.
出处 《脑与神经疾病杂志》 2018年第3期138-142,共5页 Journal of Brain and Nervous Diseases
基金 石家庄市科学技术研究与发展指导计划(151461093)
关键词 组合人工肾 血液透析滤过 血液透析 Β2-微球蛋白 尿毒症脑病 Combined artificial kidney Hemodialysis filtration Hemodialysis β2-microglobulin Uremic encephalopathy
  • 相关文献

参考文献4

二级参考文献26

  • 1龚德华,季大玺,谢红浪,徐斌,刘芸,黎磊石.连续性肾脏替代治疗剂量对溶质清除率的影响[J].中华内科杂志,2001,40(3):183-186. 被引量:17
  • 2董艳娟.尿毒症性脑病[J].脑与神经疾病杂志,2007,15(4):311-312. 被引量:19
  • 3陈灏珠.实用内科学第11版[M].北京:人民卫生出版社,2003.1589.
  • 4陈福明 邱朝霞.尿毒症脑病并发脑血管意外26例临床分析.中华肾脏病杂志,1997,13(3):178-178.
  • 5王海燕.肾脏病学[M].第二版.北京:人民卫生出版社,1998.1417.
  • 6Enomoto A,Takeda M ,Taki K,et al.Interactlons of human organic anion as well as cation transporters with indoxyl sulfate[J]. Eur J p harmacol, 2003,466:13.
  • 7Topczewska-Bwns J,Pawlak D ,Chabielska E ,et al.Increased level of 3-hydroxykynurenine in different brain regions of rats with chronic renal insufficiency[J].Brain Res Bull ,2002,58(4):423.
  • 8Lameire N,VanBiesen W,Vanholder R.Acuterenal failure[J]. Lancet, 2005,365(9457):417.
  • 9张宪安.实用病原性疾病.北京:中国医药科技出版社,1997:304-315.
  • 10张治.评价血液透析灌流治疗尿毒症脑病的疗效[J].健康之路,2013,12(7):190-191.

共引文献17

同被引文献126

引证文献9

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部